Yazhe Liu

Counsel

Disclaimer

Thank you for your interest. Before you communicate with one of our attorneys, please note: Any comments our attorneys share with you are general information and not legal advice. No attorney-client relationship will exist between you or your business and O’Melveny or any of its attorneys unless conflicts have been cleared, our management has given its approval, and an engagement letter has been signed. Meanwhile, you agree: we have no duty to advise you or provide you with legal assistance; you will not divulge any confidences or send any confidential or sensitive information to our attorneys (we are not in a position to keep it confidential and might be required to convey it to our clients); and, you may not use this contact to attempt to disqualify O’Melveny from representing other clients adverse to you or your business. By clicking "accept" you acknowledge receipt and agree to all of the terms of this paragraph and our Disclaimer.

Yazhe Liu is a counsel in O’Melveny’s Hong Kong office. Her practice focuses on capital markets, mergers & acquisitions and general corporate compliance matters of Hong Kong listed companies.

Prior to joining O’Melveny, Yazhe worked in the Hong Kong office of another international law firm.

Languages

  • Mandarin Chinese
  • English

Admissions

  • New York
  • Hong Kong

Education

  • The University of Chicago Law School, LL.M.
  • University of International Business and Economics, LL.M.; LL.B.

Capital Markets

  • Cryofocus Medtech (Shanghai) Co., Ltd. in its IPO and listing on the Hong Kong Stock Exchange
  • Jenscare Scientific Co., Ltd. in its IPO and listing on the Hong Kong Stock Exchange
  • Rainmed Medical Limited in its IPO and listing on the Hong Kong Stock Exchange
  • Goldman Sachs, J.P. Morgan and Jefferies on the US$400 million global offering and listing of JHBP (CY) Holdings on the Hong Kong Stock Exchange
  • Morgan Stanley and J.P. Morgan on the US$415 million global offering and listing of Baoxin Auto Group Limited on the Hong Kong Stock Exchange
  • Morgan Stanley and Nomura on the US$1.35 billion global offering and listing of Chongqing Rural Commercial Bank Co., Ltd. on the Hong Kong Stock Exchange
  • CMGE Technology Group Limited in its US$191 million global offering and listing on the Hong Kong Stock Exchange
  • Tencent Holdings Limited in its spin-off of China Literature Limited by way of a US$919.2 million IPO and separate listing of China Literature Limited on the Hong Kong Stock Exchange
  • Yihai International Holding Ltd. (sole supplier of hot pot soup flavoring products to Haidilao) it its US$111 million global offering and listing on the Hong Kong Stock Exchange
  • Red Star Macalline Group Corporation Ltd. in its US$931 million global offering and listing on the Hong Kong Stock Exchange
  • Oaktree Capital Management, L.P. as a cornerstone investor in the global offering and listing of JW (Cayman) Therapeutics Co. Ltd, Kangji Medical Holdings Limited and Pharmaron Beijing Co., Ltd on the Hong Kong Stock Exchange
  • SinoMedia Company Limited in its global offering and listing on the Hong Kong Stock Exchange
  • Shandong Molong Petroleum Machinery Company Limited in its migration from GEM to the Main Board of the Hong Kong Stock Exchange
  • Haitong International Securities Group Limited on a loan capitalization issue to its controlling shareholder and the subsequent offer for sale of capitalization shares by the controlling shareholder
VIEW MORE

Press Releases

In the News